levothyroxine sodium 0.125 MG Oral Capsule

RxCUI
966405
RxNorm name
levothyroxine sodium 0.125 MG Oral Capsule
Display name
levothyroxine sodium 0.125 MG Oral Capsule
Full name
levothyroxine sodium 0.125 MG Oral Capsule
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:05

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TirosintLEVOTHYROXINE SODIUMIBSA Pharma Inc.7a7ade79-0165-4e31-b84e-667416c00c7e2026-03-25Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 966405
Levothyroxine SodiumLEVOTHYROXINE SODIUMYARAL Pharma Inc.d28d7202-1278-0486-e053-2995a90af2862026-03-25Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 966405

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
7a7ade79-0165-4e31-b84e-667416c00c7elevothyroxine sodium 0.125 MG Oral CapsuleSCD13These highlights do not include all the information needed to use TIROSINT® safely and effectively. See full prescribing information for TIROSINT. TIROSINT® (levothyroxine sodium) capsules, for oral use Initial U.S. Approval: 200020260325
7a7ade79-0165-4e31-b84e-667416c00c7elevothyroxine sodium 125 MCG Oral CapsuleSY13These highlights do not include all the information needed to use TIROSINT® safely and effectively. See full prescribing information for TIROSINT. TIROSINT® (levothyroxine sodium) capsules, for oral use Initial U.S. Approval: 200020260325
7a7ade79-0165-4e31-b84e-667416c00c7elevothyroxine sodium 125 MCG Oral CapsulePSN13These highlights do not include all the information needed to use TIROSINT® safely and effectively. See full prescribing information for TIROSINT. TIROSINT® (levothyroxine sodium) capsules, for oral use Initial U.S. Approval: 200020260325
d28d7202-1278-0486-e053-2995a90af286levothyroxine sodium 125 MCG Oral CapsulePSN7These highlights do not include all the information needed to use Levothyroxine Sodium capsules safely and effectively. See full prescribing information for Levothyroxine Sodium capsules. Levothyroxine Sodium capsules, for oral use Initial U.S. Approval: 200020260325
d28d7202-1278-0486-e053-2995a90af286levothyroxine sodium 125 MCG Oral CapsuleSY7These highlights do not include all the information needed to use Levothyroxine Sodium capsules safely and effectively. See full prescribing information for Levothyroxine Sodium capsules. Levothyroxine Sodium capsules, for oral use Initial U.S. Approval: 200020260325
d28d7202-1278-0486-e053-2995a90af286levothyroxine sodium 0.125 MG Oral CapsuleSCD7These highlights do not include all the information needed to use Levothyroxine Sodium capsules safely and effectively. See full prescribing information for Levothyroxine Sodium capsules. Levothyroxine Sodium capsules, for oral use Initial U.S. Approval: 200020260325